Tech Company Financing Transactions
Alexza Pharmaceuticals Funding Round
On 1/6/2005, Alexza Pharmaceuticals raised $52 million in Series D funding from Alloy Ventures, Delphi Ventures and 5AM Ventures.
Transaction Overview
Company Name
Announced On
1/6/2005
Transaction Type
Venture Equity
Amount
$52,000,000
Round
Series D
Investors
Alloy Ventures (Lead Investor) (Leighton Read)
Delphi Ventures (Lead Investor) (Deepa Pakianathan)
Proceeds Purpose
This round of financing allows us to aggressively accelerate the development of our product candidate portfolio and further expand our technology base
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2091 Stierlin Ct.
Mountain View, CA 94043
USA
Mountain View, CA 94043
USA
Phone
Website
Email Address
Overview
Alexza Pharmaceuticals is a pharmaceutical company developing novel products for the treatment of acute and intermittent conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas King
Chief Financial Officer
Mark Oki
VP - Human Resources
Emily Kelley
VP - R & D
James Cassella
VP - Regulatory Affairs
Edwin Kamemoto
Browse more venture capital transactions:
Prev: 1/5/2005: Digital Fuel venture capital transaction
Next: 1/6/2005: BlueTarp venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs